B-hTNFR2 MC38

• 310723

B-hTNFR2 MC38

Product nameB-hTNFR2 MC38
Catalog number310723
Strain backgroundC57BL/6
AliasesCD120b, TBPII, TNFBR, TNFR80, TNFRSF1B
TissueColon
DiseaseColon carcinoma
SpeciesMouse
ApplicationB-hTNFR2 MC38 cells have the capability to establish tumors in vivo and can be used for efficacy studies.

on this page

  • Description
  • Targeting strategy
  • Phenotypic analysis
  • Tumorigenicity

Posters

View All

    Publication

      Description

      The mouse Tnfr2 gene was replaced by human TNFR2 coding sequence in B-hTNFR2 MC38 cells. Human TNFR2 is highly expressed on the surface of B-hTNFR2 MC38 cells.

      Targeting strategy

      Gene targeting strategy for B-hTNFR2 MC38 cells. The exogenous promoter and human TNFR2 coding sequence were inserted to replace the extracellular region of the mouse Tnfr2 gene. The insertion disrupts the endogenous murine Tnfr2 gene, resulting in a non-functional transcript.

      Protein expression analysis

      TNFR2 expression analysis in B-hTNFR2 MC38 cells by flow cytometry. Single cell suspensions from wild-type MC38 and B-hTNFR2 MC38 cultures were stained with species-specific anti-TNFR2 antibody. Mouse TNFR2 was detected on the surface of wild-type MC38 cells. Human TNFR2 was detected on the surface of B-hTNFR2 MC38 cells, but not on the surface of wild-type MC38 cells. The 6-D05 clone of B-hTNFR2 MC38 cells was used for in vivo experiments.

      Protein expression analysis of tumor cells

      B-hTNFR2 MC38 cells were subcutaneously transplanted into C57BL/6 mice (n=5), and on 27 days post inoculation, tumor cells were harvested and assessed for human TNFR2 expression by flow cytometry. As shown, human TNFR2 was expressed on the surface of tumor cells. Therefore, B-hTNFR2 MC38 cells can be used for in vivo efficacy studies of novel TNFR2 therapeutics.

      Tumor growth curve & Body weight changes

      Subcutaneous homograft homograft tumor growth of B-hTNFR2 MC38 cells. B-hTNFR2 MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6N mice (female, 6-9-week-old, n=5). Tumor volume and body weight were measured twice a week. (A) Average tumor volume ± SEM. (B) Body weight (Mean ± SEM). Volume was expressed in mm3 using the formula: V=0.5 X long diameter X short diameter2. As shown in panel A, B-hTNFR2 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.

      Tumor growth curve of individual mice

      B-hTNFR2 MC38 tumor growth of individual mice. B-hTNFR2 MC38 cells (5x105) and wild-type MC38 cells (5x105) were subcutaneously implanted into C57BL/6N mice (female, 6-9-week-old, n=5). As shown in panel, B-hTNFR2 MC38 cells were able to establish tumors in vivo and can be used for efficacy studies.